Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Sell
25,200
-2,400
-9% -$207K 0.77% 31
2026
Q1
$2.57M Hold
27,600
0.88% 28
2025
Q4
$2.03M Hold
27,600
0.64% 29
2025
Q3
$1.97M Sell
27,600
-9,861
-26% -$710K 0.63% 28
2025
Q2
$2.64M Sell
37,461
-12,718
-25% -$852K 0.89% 27
2025
Q1
$3.68M Sell
50,179
-16,094
-24% -$1.08M 1.43% 23
2024
Q4
$4.15M Buy
66,273
+882
+1% +$57.8K 1.44% 21
2024
Q3
$4.31M Buy
65,391
+15,484
+31% +$1.1M 1.55% 22
2024
Q2
$3.6M Buy
49,907
+36
+0.1% +$2.57K 1.33% 24
2024
Q1
$3.34M Buy
49,871
+42
+0.1% +$2.69K 1.21% 27
2023
Q4
$3.28M Buy
49,829
+12,827
+35% +$842K 1.26% 29
2023
Q3
$2.38M Sell
37,002
-4,548
-11% -$283K 1.04% 34
2023
Q2
$2.51M Buy
41,550
+35,038
+538% +$2.1M 1.13% 29
2023
Q1
$375K Buy
+6,512
New +$383K 0.18% 64

Other funds holding SHEL

Altrafin AG's SHEL Position: Q2 2026 in Review

Altrafin AG reduced its Shell (SHEL) stake by 8.7% in Q2 2026, selling an estimated $207K and leaving 25,200 shares worth $1.95M. The position accounts for 0.77% of the portfolio, ranked #31.

Altrafin AG first reported a position in SHEL in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.31M in Q3 2024. 1,523 funds tracked by Wall St. Rank hold SHEL as of Q2 2026.

  • Altrafin AG held 25,200 shares of Shell worth $1.95M as of Q2 2026.
  • Altrafin AG sold 2,400 Shell shares in Q2 2026, an estimated $207K.
  • Shell made up 0.77% of Altrafin AG's portfolio in Q2 2026, its #31 holding.
  • Altrafin AG first reported a position in Shell in Q1 2023 and has held it in 14 quarters since.
  • Altrafin AG's Shell position peaked at $4.31M in Q3 2024.
  • 1,523 funds tracked by Wall St. Rank held Shell as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.